✦ LIBER ✦

Weekly imatinib dosage for chronic eosinophilic leukaemia expressing FIP1L1-PDGFRA fusion transcript: extended follow-up

✍ Scribed by Grzegorz Helbig; Andrzej Moskwa; Alina Swiderska; Alina Urbanowicz; Małgorzata Całbecka; Justyna Gajkowska; Barbara Zdziarska; Katarzyna Brzeźniakiewicz; Joanna Pogrzeba; Sławomira Krzemień

Book ID: 108676153
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 65 KB
Volume: 145
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2008.07546.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A single weekly dose of imatinib is suff

A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients

✍ Grzegorz Helbig; Beata Stella-Hołowiecka; Mirosław Majewski; Małgorzata Całbecka 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Clinical characteristics of patients wit

Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript—results of Polish multicentre study

✍ Grzegorz Helbig; Andrzej Moskwa; Marek Hus; Jarosław Piszcz; Alina Swiderska; Al 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Abstract A small subgroup of patients with hypereosinophilic syndrome (HES) demonstrates imatinib‐sensitive fusion transcript—the FIP1L1‐PDGFRA (F/P+). These cases are currently diagnosed as chronic eosinophilic leukaemia (CEL). In this paper, we screened 77 patients to estimate the frequency of

Allogeneic bone marrow transplantation f

Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript

✍ Halaburda, K; Prejzner, W; Szatkowski, D; Limon, J; Hellmann, A 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 163 KB